Antagonistische IL-17-Antikörper

European patent · EP2902039 · Deleted

Register entry

Publication number
EP2902039
Application number
EP15156029
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 4, 2005
Published
Aug 5, 2015
Granted
Apr 11, 2018
Deleted
Aug 4, 2025
Reason
Maximum term reached
IPC classes
A61K 39/395 (2006.01)
A61P 29/00 (2006.01)
C07K 16/24 (2006.01)
Priority
GB 0417487 05.08.2004
Divided from
EP10174725
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Secukinumab

C02902039/01 · Medicine · Extended for paediatric use · Protection from Aug 4, 2025 to Feb 3, 2031

Authorisation 63295 (Swissmedic, Oct 7, 2016) · Authorisation 65225 (Swissmedic, Oct 7, 2016) · Authorisation 65226 (Swissmedic, Oct 7, 2016) · Authorisation 65226 (Swissmedic, Mar 27, 2015)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 4, 2025

    Maximum term reached

    Status of protective title
    Active → Cancelled
    Cancellation date
    04.08.2025
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 04.08.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  5. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  6. Apr 11, 2018

    Granted

    Published in Swissreg on 11.04.2018

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

Di Padova, Franco E

4127 Birsfelden

Gram, Hermann

79576 Weil am Rhein, DE

Hofstetter, Hans

4125 Riehen

Jeschke, Margit

4058 Basel

Rondeau, Jean-Michel

4002 Basel

Van Den Berg, Wim

6584 CB Molenhoek, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.